Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

ClinicalTrials.gov ID: NCT01267240

Public ClinicalTrials.gov record NCT01267240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 20, 2026, 12:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Vorinostat and Capecitabine in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) and Nasopharyngeal Carcinoma (NPC)

Study identification

NCT ID
NCT01267240
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
25 participants

Conditions and interventions

Interventions

  • Capecitabine Drug
  • Vorinostat Drug

Drug

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2010
Primary completion
May 31, 2015
Completion
Sep 30, 2016
Last update posted
Apr 13, 2017

2010 – 2016

United States locations

U.S. sites
9
U.S. states
2
U.S. cities
8
Facility City State ZIP Site status
Tower Cancer Research Foundation Beverly Hills California 90211-1850 —
City of Hope Comprehensive Cancer Center Duarte California 91010 —
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 —
Contra Costa Regional Medical Center Martinez California 94553-3156 —
Veterans Administration Hospital - Martinez Martinez California 94553 —
University of California Davis Comprehensive Cancer Center Sacramento California 95817 —
City of Hope South Pasadena South Pasadena California 91030 —
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033-0850 —
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01267240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2017 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01267240 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →